NCT02850848View on ClinicalTrials.gov

Pharmacokinetics of Two Formulations of Entecavir

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Hepatitis B
Interventions
DRUG

Entigin Film Coated Tablet 0.5mg

DRUG

(Baraclude 0.5mg Tablets

All Listed Sponsors
collaborator

Taichung Veterans General Hospital

OTHER

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT02850848 - Pharmacokinetics of Two Formulations of Entecavir | Biotech Hunter | Biotech Hunter